I really do like IMU - and for some time - I only recently sold...

I really do like IMU - and for some time - I only recently sold my shares in IMU (needed to liquidate rather than became disillusioned) and do have plans to buy back in. IMU is going to be an attractive target for partnership deals and, while it will need to go through phase 2 trials successfully and then to commercialisation stage, I do believe that both revenue and SP will rise rapidly when that process is completed.
I have no doubt that you are correct Few Pennies that the dividend could be significant. The power of IMU's concept has so great a potential (and yes, there have also been plenty of cul de sacs in biotechnology which we can't ignore) that we could see a dramatic increase in the company's value in an extremely short time after the lead in period to commercialisation.